VHL and leukemia: To overcome this problem, Adhikari et al. developed a potent AURORA-A degrader JB170 by connecting alisertib to VHL ligand, which induced rapid, durable and highly-specific degradation of AURORA-A in leukemia and neuroblastoma cells [81].